Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy
Fissolo, Nicolas, Pignolet, Béatrice, Matute-Blanch, Clara, Triviño, Juan Carlos, Miró, Berta, Mota, Miriam, Perez-Hoyos, Santiago, Sanchez, Alex, Vermersch, Patrick, Ruet, Aurélie, de Sèze, Jérôme, LLanguage:
english
Journal:
Annals of Neurology
DOI:
10.1002/ana.24987
Date:
July, 2017
File:
PDF, 1.14 MB
english, 2017